{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:45:44Z","timestamp":1795023944608,"version":"4.10.2"},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016834","name":"Chongqing Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82325008"],"award-info":[{"award-number":["82325008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.livres.2023.11.003","type":"journal-article","created":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T17:44:17Z","timestamp":1700415857000},"page":"285-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions"],"prefix":"10.1016","volume":"7","author":[{"given":"Zhixian","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2023.11.003_bib1","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2023.11.003_bib2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2023.11.003_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MOL.0000000000000080","article-title":"Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans","volume":"25","author":"Jacome-Sosa","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.livres.2023.11.003_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/j.livres.2023.11.003_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2023.11.003_bib6","first-page":"E321","article-title":"Role of human liver lipogenesis and reesterification in triglycerides secretion and in FFA reesterification","volume":"274","author":"Diraison","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.livres.2023.11.003_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/ajcn\/73.2.253","article-title":"Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men","volume":"73","author":"Marques-Lopes","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.livres.2023.11.003_bib8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2023.11.003_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031812","article-title":"Liver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass","volume":"7","author":"Knebel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2023.11.003_bib10","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/nm.3372","article-title":"Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin","volume":"19","author":"Fullerton","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2023.11.003_bib11","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.2337\/db15-0370","article-title":"Growth hormone inhibits hepatic de novo lipogenesis in adult mice","volume":"64","author":"Cordoba-Chacon","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.livres.2023.11.003_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metabol"},{"key":"10.1016\/j.livres.2023.11.003_bib13","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.11.003_bib14","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1172\/JCI118645","article-title":"Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet","volume":"97","author":"Hudgins","year":"1996","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2023.11.003_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.livres.2023.11.003_bib16","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41574-019-0256-9","article-title":"The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state","volume":"15","author":"Hodson","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.livres.2023.11.003_bib17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.molmed.2017.09.001","article-title":"Targeting ATP-citrate lyase in hyperlipidemia and metabolic disorders","volume":"23","author":"Pinkosky","year":"2017","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.livres.2023.11.003_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.nutr.012809.104729","article-title":"Lipins: multifunctional lipid metabolism proteins","volume":"30","author":"Csaki","year":"2010","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.livres.2023.11.003_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1463-1326.2010.01275.x","article-title":"Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c","volume":"12","author":"Ferr\u00e9","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib20","first-page":"72","article-title":"SREBP-1c transcription factor and lipid homeostasis: clinical perspective","volume":"68","author":"Ferr\u00e9","year":"2007","journal-title":"Horm Res"},{"key":"10.1016\/j.livres.2023.11.003_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1042\/bj20020430","article-title":"New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c","volume":"366","author":"Foufelle","year":"2002","journal-title":"Biochem J"},{"key":"10.1016\/j.livres.2023.11.003_bib22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2023.11.003_bib23","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/s42255-021-00501-9","article-title":"Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity","volume":"3","author":"Tilg","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2015.03.032","article-title":"Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts","volume":"63","author":"Ma","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.11.003_bib25","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.11.003_bib26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature10986","article-title":"A\u00a0novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism","volume":"484","author":"Herman","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.livres.2023.11.003_bib27","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1172\/JCI94585","article-title":"Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling","volume":"127","author":"Softic","year":"2017","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2023.11.003_bib28","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2337\/diabetes.53.3.560","article-title":"Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice","volume":"53","author":"Matsuzaka","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.livres.2023.11.003_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1194\/jlr.M049130","article-title":"Liver X receptor regulates hepatic nuclear O-GlcNAc signaling and carbohydrate responsive element-binding protein activity","volume":"56","author":"Bindesb\u00f8ll","year":"2015","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.livres.2023.11.003_bib30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.cmet.2009.01.011","article-title":"The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance","volume":"9","author":"Nagai","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cmet.2017.12.016","article-title":"The small intestine converts dietary fructose into glucose and organic acids","volume":"27","author":"Jang","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-020-2101-7","article-title":"Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate","volume":"579","author":"Zhao","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.livres.2023.11.003_bib33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2023.11.003_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cmet.2007.12.009","article-title":"Selective versus total insulin resistance: a pathogenic paradox","volume":"7","author":"Brown","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/01.mco.0000172589.55434.03","article-title":"Modulation of insulin action by dietary proteins and amino acids: role of the mammalian target of rapamycin nutrient sensing pathway","volume":"8","author":"Tremblay","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.livres.2023.11.003_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","article-title":"Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1","volume":"3","author":"Um","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib37","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1172\/JCI37007","article-title":"GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice","volume":"119","author":"Kammoun","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.livres.2023.11.003_bib38","doi-asserted-by":"crossref","first-page":"22678","DOI":"10.1074\/jbc.M704213200","article-title":"Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance","volume":"282","author":"Choi","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2023.11.003_bib39","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cmet.2015.06.007","article-title":"Targeted induction of ceramide degradation leads to improved systemic metabolism and reduced hepatic steatosis","volume":"22","author":"Xia","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib40","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2023.11.003_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.livres.2023.11.003_bib42","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jhep.2018.08.008","article-title":"miRNAs in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"69","author":"Liu","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.11.003_bib43","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1080\/15476286.2015.1112487","article-title":"MicroRNAs activate gene transcription epigenetically as an enhancer trigger","volume":"14","author":"Xiao","year":"2017","journal-title":"RNA Biol"},{"key":"10.1016\/j.livres.2023.11.003_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","article-title":"miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease","volume":"25","author":"Long","year":"2019","journal-title":"Mol Med"},{"key":"10.1016\/j.livres.2023.11.003_bib45","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/cbdd.12398","article-title":"Up regulation of liver-enriched transcription factors HNF4a and HNF6 and liver-specific microRNA (miR-122) by inhibition of let-7b in mesenchymal stem cells","volume":"85","author":"Alizadeh","year":"2015","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.livres.2023.11.003_bib46","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hep.27153","article-title":"Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia","volume":"60","author":"Ng","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.11.003_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.lfs.2018.07.029","article-title":"Plasma miR-17, miR-20a, miR-20b and miR-122 as potential biomarkers for diagnosis of NAFLD in type 2 diabetes mellitus patients","volume":"208","author":"Ye","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.livres.2023.11.003_bib48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics - challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.livres.2023.11.003_bib49","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.pt.2023.07.001","article-title":"microRNAs in parasite-induced liver fibrosis: from mechanisms to diagnostics and therapeutics","volume":"39","author":"Liu","year":"2023","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.livres.2023.11.003_bib50","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/nar\/gky1239","article-title":"Diverse lipid conjugates for functional extra-hepatic siRNA delivery in\u00a0vivo","volume":"47","author":"Biscans","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.livres.2023.11.003_bib51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jhep.2010.03.004","article-title":"Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22","volume":"53","author":"Yang","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.11.003_bib52","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1017\/S0954422421000202","article-title":"Carbohydrates deteriorate fatty liver by activating the inflammatory response","volume":"35","author":"Gao","year":"2022","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.livres.2023.11.003_bib53","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/jhep.2003.50316","article-title":"Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E","volume":"38","author":"Kugelmas","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.11.003_bib54","doi-asserted-by":"crossref","first-page":"101349","DOI":"10.1016\/j.molmet.2021.101349","article-title":"The hepatocyte IKK:NF-\u03baB axis promotes liver steatosis by stimulating de novo lipogenesis and cholesterol synthesis","volume":"54","author":"Heida","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.31249","article-title":"The IKK\u03b2-USP30-ACLY axis controls lipogenesis and tumorigenesis","volume":"73","author":"Gu","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.11.003_bib56","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cellsig.2005.05.007","article-title":"Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes","volume":"18","author":"Zmuda-Trzebiatowska","year":"2006","journal-title":"Cell Signal"},{"key":"10.1016\/j.livres.2023.11.003_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3390\/antiox10020174","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.livres.2023.11.003_bib58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.redox.2015.11.010","article-title":"Interplay between oxidant species and energy metabolism","volume":"8","author":"Quijano","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.livres.2023.11.003_bib59","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2008.08.068","article-title":"Oxidative stress induced lipid accumulation via SREBP1c activation in HepG2 cells","volume":"375","author":"Sekiya","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.livres.2023.11.003_bib60","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2023.11.003_bib61","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1152\/ajpendo.00441.2010","article-title":"Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL\/6J mice","volume":"300","author":"Murase","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib62","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.11.003_bib63","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3390\/nu6083303","article-title":"Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition","volume":"6","author":"Lee","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2023.11.003_bib64","doi-asserted-by":"crossref","first-page":"108319","DOI":"10.1016\/j.jnutbio.2019.108319","article-title":"The nonalcoholic fatty liver disease-like phenotype and lowered serum VLDL are associated with decreased expression and DNA hypermethylation of hepatic ApoB in male offspring of ApoE deficient mothers fed a with Western diet","volume":"77","author":"Chen","year":"2020","journal-title":"J\u00a0Nutr Biochem"},{"key":"10.1016\/j.livres.2023.11.003_bib65","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.molmet.2017.07.016","article-title":"Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease","volume":"6","author":"Baumeier","year":"2017","journal-title":"Mol Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib66","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1158\/2159-8290.CD-20-0519","article-title":"Epigenetic and transcriptional control of the epidermal growth factor receptor regulates the tumor immune microenvironment in pancreatic cancer","volume":"11","author":"Li","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.livres.2023.11.003_bib67","article-title":"PINK1-Parkin-mediated mitophagy protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2023.11.003_bib68","series-title":"Cancer Immunology: A Translational Medicine Context","first-page":"513","article-title":"Immunosenescence, Oxidative Stress, and Cancers","author":"Fulop","year":"2020"},{"key":"10.1016\/j.livres.2023.11.003_bib69","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","article-title":"Targeting oxidative stress in disease: promise and limitations of antioxidant therapy","volume":"20","author":"Forman","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.livres.2023.11.003_bib70","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00535-018-1451-5","article-title":"To die or not to die: death signaling in nonalcoholic fatty liver disease","volume":"53","author":"Akazawa","year":"2018","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.livres.2023.11.003_bib71","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ceb.2009.12.003","article-title":"Necroptosis as an alternative form of programmed cell death","volume":"22","author":"Christofferson","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.livres.2023.11.003_bib72","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.1172308","article-title":"RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis","volume":"325","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.livres.2023.11.003_bib73","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2468-1253(21)00261-2","article-title":"Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review","volume":"7","author":"Mantovani","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2023.11.003_bib74","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.3748\/wjg.v18.i18.2203","article-title":"Effect of soy protein supplementation in patients with chronic hepatitis C: a randomized clinical trial","volume":"18","author":"Oliveira","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2023.11.003_bib75","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3945\/ajcn.2008.27296","article-title":"High protein intake reduces intrahepatocellular lipid deposition in humans","volume":"90","author":"Bortolotti","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.livres.2023.11.003_bib76","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.jhep.2011.08.018","article-title":"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"56","author":"Parker","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2023.11.003_bib77","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.3390\/nu13082617","article-title":"Omega-3 polyunsaturated fatty acid: a pharmaco-nutraceutical approach to improve the responsiveness to ursodeoxycholic acid","volume":"13","author":"Th\u00e9rien","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2023.11.003_bib78","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2010.1505","article-title":"Effects of diet and physical activity interventions on weight loss and cardiometabolic risk factors in severely obese adults: a randomized trial","volume":"304","author":"Goodpaster","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.livres.2023.11.003_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/japplphysiol.00127.2012","article-title":"Short-term exercise reduces markers of hepatocyte apoptosis in nonalcoholic fatty liver disease","volume":"113","author":"Fealy","year":"2012","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.livres.2023.11.003_bib80","first-page":"2416","article-title":"Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity","volume":"310","author":"Courcoulas","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.livres.2023.11.003_bib81","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jama.2017.20813","article-title":"Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study","volume":"319","author":"Ikramuddin","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.livres.2023.11.003_bib82","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.11.003_bib83","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.11.003_bib84","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","article-title":"Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease","volume":"66","author":"Rotman","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.livres.2023.11.003_bib85","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/nu9020096","article-title":"Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD)","volume":"9","author":"Chen","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2023.11.003_bib86","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41573-021-00367-2","article-title":"Lipogenesis inhibitors: therapeutic opportunities and challenges","volume":"21","author":"Batchuluun","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.livres.2023.11.003_bib87","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1432-1033.1972.tb01801.x","article-title":"Kinetic study of the tricarboxylate carrier in rat liver mitochondria","volume":"26","author":"Klingenberg","year":"1972","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.livres.2023.11.003_bib88","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41418-018-0101-z","article-title":"The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer","volume":"25","author":"Fernandez","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.livres.2023.11.003_bib89","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1038\/s41418-020-0491-6","article-title":"Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD\/NASH","volume":"27","author":"Tan","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.livres.2023.11.003_bib90","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.bbagrm.2014.07.013","article-title":"A\u00a0key role of the mitochondrial citrate carrier (SLC25A1) in TNF\u03b1- and IFN\u03b3-triggered inflammation","volume":"1839","author":"Infantino","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.livres.2023.11.003_bib91","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.18632\/oncotarget.714","article-title":"The mitochondrial citrate transporter, CIC, is essential for mitochondrial homeostasis","volume":"3","author":"Catalina-Rodriguez","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.livres.2023.11.003_bib92","doi-asserted-by":"crossref","first-page":"3683026","DOI":"10.1155\/2018\/3683026","article-title":"Combination of mitochondrial and plasma membrane citrate transporter inhibitors inhibits de novo lipogenesis pathway and triggers apoptosis in hepatocellular carcinoma cells","volume":"2018","author":"Poolsri","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.livres.2023.11.003_bib93","doi-asserted-by":"crossref","first-page":"1081262","DOI":"10.3389\/fgene.2022.1081262","article-title":"SLC25A1-associated prognostic signature predicts poor survival in acute myeloid leukemia patients","volume":"13","author":"Liu","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.livres.2023.11.003_bib94","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0003-9861(69)90532-3","article-title":"Tricarballylate and hydroxycitrate: substrate and inhibitor of ATP: citrate oxaloacetate lyase","volume":"135","author":"Watson","year":"1969","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.livres.2023.11.003_bib95","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1021\/jo00061a031","article-title":"Purpurone, an inhibitor of ATP-citrate lyase: a novel alkaloid from the marine sponge Iotrochota sp","volume":"58","author":"Chan","year":"1993","journal-title":"J\u00a0Org Chem"},{"key":"10.1016\/j.livres.2023.11.003_bib96","doi-asserted-by":"crossref","first-page":"39231","DOI":"10.1074\/jbc.M006192200","article-title":"Radicicol binds and inhibits mammalian ATP citrate lyase","volume":"275","author":"Ki","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2023.11.003_bib97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2014.03.015","article-title":"Inactivation of ATP citrate lyase by Cucurbitacin B: a bioactive compound from cucumber, inhibits prostate cancer growth","volume":"349","author":"Gao","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.livres.2023.11.003_bib98","doi-asserted-by":"crossref","first-page":"13457","DOI":"10.1038\/ncomms13457","article-title":"Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis","volume":"7","author":"Pinkosky","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.livres.2023.11.003_bib99","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cmet.2022.05.004","article-title":"Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia","volume":"34","author":"Morrow","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/cpdd.782","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of a liver-targeting Acetyl-CoA carboxylase inhibitor (PF-05221304): a three-part randomized phase 1 study","volume":"9","author":"Bergman","year":"2020","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.livres.2023.11.003_bib101","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/toxsci\/kfaa169","article-title":"Inhibition of Acetyl-CoA carboxylase causes malformations in rats and rabbits: comparison of mammalian findings and alternative assays","volume":"179","author":"Catlin","year":"2021","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.livres.2023.11.003_bib102","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s42255-020-00272-9","article-title":"De novo lipogenesis is essential for platelet production in humans","volume":"2","author":"Kelly","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib103","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1038\/s41591-021-01489-1","article-title":"ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials","volume":"27","author":"Calle","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2023.11.003_bib104","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.cgh.2018.04.042","article-title":"Acetyl-CoA carboxylase inhibitor GS-0976 for 12 weeks reduces hepatic de novo lipogenesis and steatosis in patients with nonalcoholic steatohepatitis","volume":"16","author":"Lawitz","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2023.11.003_bib105","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1053\/j.gastro.2018.07.027","article-title":"GS-0976 reduces hepatic steatosis and fibrosis markers in patients with nonalcoholic fatty liver disease","volume":"155","author":"Loomba","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.11.003_bib106","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0163-7827(02)00067-X","article-title":"Structural and functional organization of the animal fatty acid synthase","volume":"42","author":"Smith","year":"2003","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.livres.2023.11.003_bib107","doi-asserted-by":"crossref","first-page":"9011","DOI":"10.1074\/jbc.R800068200","article-title":"Mitochondrial fatty acid synthesis type II: more than just fatty acids","volume":"284","author":"Hiltunen","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2023.11.003_bib108","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1074\/jbc.M310512200","article-title":"ATP-citrate lyase deficiency in the mouse","volume":"279","author":"Beigneux","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.livres.2023.11.003_bib109","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0505714102","article-title":"Mutant mice lacking acetyl-CoA carboxylase 1 are embryonically lethal","volume":"102","author":"Abu-Elheiga","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2023.11.003_bib110","doi-asserted-by":"crossref","first-page":"6358","DOI":"10.1073\/pnas.0931394100","article-title":"Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero","volume":"100","author":"Chirala","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.livres.2023.11.003_bib111","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.cmet.2017.08.011","article-title":"Acetyl CoA carboxylase inhibition reduces hepatic steatosis but elevates plasma triglycerides in mice and humans: a bedside to bench investigation","volume":"26","author":"Kim","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2023.11.003_bib112","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568423000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568423000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T05:41:45Z","timestamp":1744868505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568423000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2542568423000648"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2023.11.003","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-depth analysis of de novo lipogenesis in non-alcoholic fatty liver disease: Mechanism and pharmacological interventions","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2023.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}